Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Zentiva Pharma UK Limited, 12 New Fetter Lane, London, EC4A 1JP, United Kingdom Trading as: Zentiva, 12 New Fetter Lane, London EC4A 1JP, United Kingdom
Molipaxin 50 mg Capsules/Trazodone hydrochloride 50 mg Capsules.
Pharmaceutical Form |
---|
Capsules. |
Trazodone hydrochloride 50 mg per capsule.
Excipients with known effect: Each tablet contains 78.3 mg lactose.
For a full list of excipients, see 6.1.
Active Ingredient | Description | |
---|---|---|
Trazodone |
Trazodone is a potent antidepressant. It also has anxiety reducing activity. Trazodone is a triazolopyridine derivative chemically unrelated to known tricyclic, tetracyclic and other antidepressant agents. It has negligible effect on noradrenaline re-uptake mechanisms. |
List of Excipients |
---|
Lactose |
Zentiva Pharma UK Limited, 12 New Fetter Lane, London, EC4A 1JP, United Kingdom
Trading as: Zentiva, 12 New Fetter Lane, London EC4A 1JP, United Kingdom
PL 17780/0617
13/05/1999
Drug | Countries | |
---|---|---|
MOLIPAXIN | Ireland, Malta, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.